Cargando…
1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study
Autores principales: | Nichetti, F., Bini, M., Dotti, K.F., Ottini, A., Ambrosini, M., Rametta, A., Leporati, R., Ferrari, L., De Braud, F.G.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506452/ http://dx.doi.org/10.1016/j.annonc.2020.08.1766 |
Ejemplares similares
-
COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study
por: Nichetti, Federico, et al.
Publicado: (2020) -
CovInter: interaction data between coronavirus RNAs and host proteins
por: Amahong, Kuerbannisha, et al.
Publicado: (2022) -
1702 A Comparative Analysis of Tuberculous and Brucellar Spondylodiscitis
por: Koubaa, Makram, et al.
Publicado: (2014) -
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan
por: Pietrantonio, Filippo, et al.
Publicado: (2020) -
1702. Disseminated Candidiasis after Candidemia: Epidemiology, Diagnostic Evaluation, and Risk Factors
por: Whitehurst, Daniel, et al.
Publicado: (2023)